The main barrier to the success of hematopoietic stem cell transplantation (HSCT) is acute graft versus host disease (aGVHD). The risk factors for aGVHD are mainly clinical and can be improved if additional biological factors are incorporated, such as the metabolomic profile.
No takes yet. Share an insight, caveat, or question.
Ferreira et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: